EPISODE · Jun 8, 2026 · 18 MIN
Calidi Biotherapeutics - $CLDI - Ep:069 - Nano Cap Podcast
from Nano Cap Podcast · host Will Tjernlund
In this interview, biotech CEO Eric Poma discusses the groundbreaking science behind Calidi Biotherapeutics oncolytic virus platform, its potential to revolutionize cancer treatment, and the company's development roadmap. Gain insights into innovative cancer therapies, clinical trial strategies, and future prospects.Calidi Biotherapeutics: https://www.calidibio.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
What this episode covers
In this interview, biotech CEO Eric Poma discusses the groundbreaking science behind Calidi Biotherapeutics oncolytic virus platform, its potential to revolutionize cancer treatment, and the company's development roadmap. Gain insights into innovative cancer therapies, clinical trial strategies, and future prospects.Calidi Biotherapeutics: https://www.calidibio.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
NOW PLAYING
Calidi Biotherapeutics - $CLDI - Ep:069 - Nano Cap Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.